US Patent Issued to BAST BIOTECHNOLOGY on Feb. 10 for "Compositions and methods for treatment of fibrosis" (Illinois Inventor)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,394, issued on Feb. 10, was assigned to BAST BIOTECHNOLOGY (Chicago).

"Compositions and methods for treatment of fibrosis" was invented by Adam Elhofy (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates, in general, to compositions comprising phosphatidylcholine and phosphatidylcholine derivatives, e.g., DLPC (1, 2-dilauroyl-sn-glycero-3-phosphocholine) or DPPC, for the treatment of fibrosis, including liver fibrosis and associated conditions such as fatty liver disease, non-alcoholic steatohepatitis (NASH) and cirrhosis, or lung fibrosis and conditions associated with lung fibrosis."

The patent was filed on Oct. ...